10월20일(목)대학원세미나 Prof. Chan Hyuk Kim(Department of Biological Sciences, KAIST, South Korea)

by 관리자 posted Oct 19, 2016
?

단축키

Prev이전 문서

Next다음 문서

ESC닫기

크게 작게 위로 아래로 댓글로 가기 인쇄
Extra Form
초청강사 Prof. Chan Hyuk Kim
소속 Department of Biological Sciences, KAIST, South Korea
일시 2016년 10월 20일(목) 오후5시
장소 아산이학관 331

“Novel Small Molecule-based Approaches for Cancer Immunotherapy”


Cancer immunotherapy has been drawing growing attention as a novel promising therapeutic modality for cancer. Unlike conventional chemo- or radiotherapy, immunotherapy treats cancer by unleashing the suppressed activity of the patient’s own immune system and harnessing its power to fight cancer, to achieve robust anti-tumor responses while minimizing collateral damages to normal tissues. In particular, T cell-based immunotherapeutics such as bispecific antibodies and chimeric antigen receptor (CAR) T cells have generated unprecedented responses in clinics, and have become promising therapeutic modalities for the treatment of refractory cancers. Despite their success, however, there are several issues, such as unfavorable pharmacokinetics and biophysical properties as well as safety-related issues, associated with these biological drugs, preventing more widespread and safe application of these promising therapeutics. In this talk, I will discuss our recent efforts on addressing these issues by using synthetic small molecule ligands and biorthogonal conjugation chemistry to generate next-generation cancer immunotherapeutics.


20161020_세미나_Prof. Chan Hyuk Kim.hwp